Author | Badar M. Mian, MD


Is a reduced bacillus Calmette-Guérin regimen feasible?

June 02, 2020


"In the era of BCG shortage, it would have been highly desirable to demonstrate the efficacy and safety of fewer BCG instillations for high-risk bladder cancer. However, reduced frequency of maintenance BCG instillations is associated with increased risk of cancer recurrence, albeit with fewer adverse effects," writes Badar M. Mian, MD.

Study shows benefit of adjuvant chemo after nephroureterectomy

May 07, 2020


"This important trial supports the use of adjuvant chemotherapy after nephroureterectomy for stage T2 or higher cases," writes Badar M M. Mian, MD.

Surveillance safe for patients with Grade Group 1 prostate Ca

April 06, 2020


"Death due to prostate cancer was quite rare, with only four men (0.2%) dying of prostate cancer during the study period," writes Badar M. Mian, MD.

Sequential gemcitabine/docetaxel promising for recurrent NMIBC

February 28, 2020


"In this era of BCG shortage, we may be forced to develop new standards and alternative strategies for bladder preservation," writes Badar M. Mian, MD.